Home › Funds › Royce & Associates › RGEN
Royce & Associates position in RGEN
REPLIGEN CORP · Health Care
Latest position (Q2 2026)174.79K sh
Reported value held$23.85M
Portfolio Weight0.19%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 90.20K | $16.97M | New |
| Q2 2022 | 127.22K | $20.66M | Add |
| Q3 2022 | 100.09K | $18.73M | Reduce |
| Q4 2022 | 92.44K | $15.65K | Reduce |
| Q1 2023 | 10.74K | $1.81K | Reduce |
| Q2 2025 | 89.52K | $11.13M | New |
| Q3 2025 | 148.66K | $19.87M | Add |
| Q4 2025 | 146.97K | $24.08M | Reduce |
| Q1 2026 | 115.93K | $13.66M | Reduce |
| Q2 2026 | 174.79K | $23.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RGEN
- Vanguard Group 4.99M sh · $818.31M · Q4 2025
- Maverick Capital 1.98M sh · $270.77M · Q2 2026
- MFS Investment Management 1.62M sh · $220.61M · Q2 2026
- Invesco Ltd 1.39M sh · $189.28M · Q2 2026
- Geode Capital Management 1.06M sh · $145.00M · Q2 2026
- UBS Group AG 795.01K sh · $108.47M · Q2 2026
- Baron Funds 748.47K sh · $102.12M · Q2 2026
- Norges Bank Investment Management 575.23K sh · $78.48M · Q2 2026
- Charles Schwab Investment Management 481.74K sh · $65.73M · Q2 2026
- Northern Trust Corp 444.15K sh · $60.60M · Q2 2026
- Citadel Advisors 427.11K sh · $58.27M · Q2 2026
- Bank of America Corp 426.29K sh · $58.16M · Q2 2026